Healthcare · Pharmaceuticals & Biotechnology
The largest companies in the same industry by market cap. This company ranks #20 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.
| Company | Market cap (₹ Cr) | PE (TTM) | ROE | 1Y return | Div. yield | Quality | Valuation | Momentum |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 427,010 | 143.5 | 13.7% | 7.6% | — | 72 | 8 | 30 |
| Divi's Laboratories Limited | 244,125 | 83.0 | 15.3% | 57.8% | 0.33% | 70 | 4 | 51 |
| Torrent Pharmaceuticals Limited | 161,506 | 77.7 | 12.2% | 35.3% | 0.80% | 56 | 0 | 31 |
| Zydus Lifesciences Limited | 113,616 | 32.6 | 17.3% | 14.5% | 0.09% | 74 | 24 | 84 |
| Cipla Limited | 107,888 | 35.1 | 11.2% | -11.7% | 0.97% | 73 | 29 | 62 |
| Laurus Labs Limited | 106,505 | 122.0 | 17.1% | 128.4% | — | 78 | 24 | 53 |
| Mankind Pharma Limited | 102,382 | 46.9 | 11.7% | 0.9% | — | 68 | 12 | 86 |
| Dr. Reddy's Laboratories Limited | 100,411 | 150.9 | 10.9% | -3.7% | — | 62 | 33 | 71 |
| Emcure Pharmaceuticals Limited (this stock) | 36,743 | 45.3 | 18.9% | 35.0% | 0.19% | 78 | 33 | 50 |
| Period end | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) | Basic EPS |
|---|---|---|---|---|
| June 30, 2026 | 2,580 | 394 | 292 | ₹ |
| March 31, 2026 | 2,470 | 341 | 244 | ₹ |
| Dec. 31, 2025 | 2,363 | 314 | 231 | ₹ |
| Sept. 30, 2025 | 2,270 | 341 | 251 | ₹ |
| June 30, 2025 | 2,101 | 291 | 215 | ₹ |
| March 31, 2025 | 2,116 | 261 | 197 | ₹ |
| Dec. 31, 2024 | 1,963 | 230 | 156 | ₹ |
| Sept. 30, 2024 | 2,002 | 273 | 202 | ₹ |
| June 30, 2024 | 1,815 | 207 | 153 | ₹ |
The detailed income statement is standalone-only: the consolidated feed carries just revenue, PBT and net profit.
| Year ended | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) |
|---|---|---|---|
| March 31, 2026 | 9,204 | 1,287 | 941 |
| March 31, 2025 | 7,896 | 971 | 707 |
Data unavailable.
| Year ended | Operating (₹ Cr) | Investing (₹ Cr) | Financing (₹ Cr) | Capex (₹ Cr) | Free Cash Flow (₹ Cr) |
|---|---|---|---|---|---|
| March 31, 2026 | 944 | -1,193 | 343 | 361 | 583 |
| March 31, 2025 | 852 | -94 | -814 | 222 | 630 |
| Year ended | Total Assets (₹ Cr) | Total Equity (₹ Cr) | Reserves (₹ Cr) | Borrowings, Current (₹ Cr) | Borrowings, Non-current (₹ Cr) | Current Assets (₹ Cr) | Current Liabilities (₹ Cr) | Cash & Equivalents (₹ Cr) | Net Block (₹ Cr) | Inventory (₹ Cr) |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | 9,612 | 4,977 | 4,760 | 952 | 252 | 5,709 | 3,912 | 137 | 1,960 | 2,398 |
| March 31, 2025 | 8,233 | 4,642 | 4,257 | 542 | 190 | 4,650 | 2,668 | 156 | 1,954 | 1,932 |
